Neoplasm Metastasis: all 3,564 studies
Page 25 of 36. Open to participants first (875), then studies with results posted, then the rest; newest registration first within each.
- Detection of CSF Next Generation Sequencing in the Application of Brain Metastases From Lung Adenocarcinoma or Meningeal MetastasisStatus unknownNCT03029065
- Tomotherapy for Refractory Brain MetastasesStatus unknownNCT03027544Not applicable
- A Study of Merestinib (LY2801653) in Japanese Participants With Advanced or Metastatic CancerCompletedNCT03027284Phase 1
- Intravenous Paricalcitol in Chronic Hemodialysis PatientsStatus unknownNCT03023748Phase 4
- A Study of Evorpacept (ALX148) in Patients With Advanced Solid Tumors and Lymphoma (ASPEN-01)CompletedNCT03013218Phase 1
- The P10s-PADRE Basket Trial: Vaccination of Metastatic Cancer PatientsWithdrawnNCT03003195Phase 2
- Hippocampal-sparing Whole Brain Radiotherapy for Brain Metastases From Breast CancerStatus unknownNCT03002532Not applicable
- Validation of Radio-induced Damage BiomarkersTerminatedNCT02999152Not applicable
- A Phase Ib/II Study of Efficacy and Feasibility of Cytoreductive Surgery, Extensive Peritoneal Lavage, Hyperthermicintraperitoneal Chemotherapy and Post-operative Intraperitoneal Chemotherapy Combination in Gastric Cancer With Peritoneal MetastasisCompletedNCT02995850Phase 1/2
- A Phase I Study With Lymfactin® in the Treatment of Patients With Secondary LymphedemaTerminatedNCT02994771Phase 1
- Predict the Risk of Axillary Metastases in Breast Cancer Patients With Axillary UltrasoundStatus unknownNCT02992769
- MAGE-A10ᶜ⁷⁹⁶T for Urothelial Cancer, Melanoma or Head and Neck CancersCompletedNCT02989064Phase 1
- Combining Radiosurgery and Nivolumab in the Treatment of Brain MetastasesCompletedNCT02978404Phase 2
- Immunization Strategy With Intra-tumoral Injections of Pexa-Vec With Ipilimumab in Metastatic / Advanced Solid Tumors.CompletedNCT02977156Phase 1
- A Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001)Active, not recruitingNCT02974738Phase 1
- Open Label, Prospective Study to Investigate Efficacy and Safety of AZD9291 in BM From NSCLC Patients With EGFR T790MStatus unknownNCT02972333Phase 3
- Whole Versus Partial Vertebral Body IMRT for Spinal MetastasesStatus unknownNCT02972229Not applicable
- Prospecitve Observational Study on a Risk Adaptive Scheme for SBRT for Thoracic Nodes MetastasesCompletedNCT02970955
- 18F-NaF-PET/MR vs 99mTc-MDP-SPECT/CT to Detect Bone Metastases in Prostate Cancer Patients.CompletedNCT02969564
- Study to Compare DITEST to Testosterone Undecanoate in Adult Men With HypogonadismCompletedNCT02966652Phase 1
- Magnetic Resonance Imaging of the Whole Body, Including Diffusion, in the Medical Evaluation of Breast Cancers at High Risk for Metastasis and the Follow-up of Metastatic CancersStatus unknownNCT02966574Not applicable
- Study of Natural Killer Cells in Patients With Metastatic Prostate Cancer: Relationship With Survival and Response Time to CastrationCompletedNCT02963155Not applicable
- Simultaneous Resection of Colorectal Cancer With Synchronous Liver MetastasesCompletedNCT02954913Not applicable
- Cognitive Outcome After Gamma Knife Radiosurgery in Patients With Brain Metastases (CAR-Study A)CompletedNCT02953756
- Cognitive Outcome After SRS or WBRT in Patients With Multiple Brain Metastases (CAR-Study B)CompletedNCT02953717Not applicable
- Clinical Evaluation of PET-CT for Staging of Colorectal Lung MetastasesCompletedNCT02942901
- Transarterial Radioembolisation in Comparison to Transarterial Chemoembolisation in Uveal Melanoma Liver MetastasisCompletedNCT02936388Phase 2
- Metastatic Spinal Cord Compression (MSCC): Treatment Timing and Survival RateStatus unknownNCT02934594
- Stereotactic Ablative Body Radiotherapy (SABR) for OligometastasesActive, not recruitingNCT02933242Not applicable
- Study of LYC-55716 in Adult Subjects With Locally Advanced or Metastatic CancerCompletedNCT02929862Phase 1/2
- An Open-Label Phase 1/2 Study of Itacitinib in Combination With Osimertinib in Subjects With Non-Small Cell Lung CancerCompletedNCT02917993Phase 1/2
- EpCAM CAR-T for Treatment of Advanced Solid TumorsActive, not recruitingNCT02915445Phase 1
- Hypofractionated Stereotactic Radiation Therapy of Brain Metastases: Evaluation of Whole-brain RadiotherapyCompletedNCT02913534
- Yttrium90, Ipilimumab, & Nivolumab for Uveal Melanoma With Liver MetastasesStatus unknownNCT02913417Phase 1/2
- Perioperative Chemotherapy VS Postoperative Chemotherapy for the Treatment of Colon Cancer With Resectable Liver MetastasisStatus unknownNCT02912052Phase 3
- Effectiveness of Oral Alfacalcidol for Secondary Hyperparathyroidism in Chronic Hemodialysis Patients.CompletedNCT02895061Not applicable
- Hepatic Resection for Metastatic Pancreatic CancerActive, not recruitingNCT02892305
- Hypofractionated Brain Radiation In EGFR Mutated Adenocarcinoma Cranial Disease (Hybrid)Status unknownNCT02882984Phase 3
- Dendritic Killer Cell-based Immunotherapy for Solid TumorsStatus unknownNCT02882659Phase 1
- Dose-finding, Safety and Efficacy Study of Radium-223 Dichloride (XOFIGO) in RCC Patients With Bone Metastases. (EIFFEL)Status unknownNCT02880943Phase 1/2
- nTMS for Motor Mapping of Rolandic LesionsCompletedNCT02879682Phase 2/3
- Evaluation of Sodium Fluoride PET in the Identification of Bone Metastases in Patients Having Undergone a Choline PET for Occult Recurrence of Prostatic AdenocarcinomaStatus unknownNCT02876991Not applicable
- Comparison of NaF PET-CT and Diffusion MRI in the Diagnosis of Bone Metastases (IMMETAOS)CompletedNCT02876731Not applicable
- Observation for Patients With Asymptomatic CNS Metastatic DiseaseCompletedNCT02866981Phase 2
- Resection Versus Microwave Ablation for Resectable Colorectal Cancer Liver MetastasesTerminatedNCT02866344Not applicable
- Investigating the Safety, Tolerability and Efficacy of Amorphous Calcium Carbonate (ACC) on the Treatment of Subjects With CRPCWithdrawnNCT02864784Phase 1
- A Study of MG7 Redirected Autologous T Cells for Advanced MG7 Positive Liver Metastases(MG7-CART)Status unknownNCT02862704Phase 1/2
- Atezolizumab in Treating Patients With Cancer Following Adoptive Cell TransferActive, not recruitingNCT02862275Phase 1
- A Study of Prexasertib (LY2606368) in Combination With Ralimetinib in Participants With Advanced or Metastatic CancerCompletedNCT02860780Phase 1
- Evaluation of an Organized Consultation "Return Home" of Patients With a Cancer (CREDO)CompletedNCT02857400Not applicable
- Nintedanib Plus mFOLFOX6 for Previously Untreated Metastatic Esophagogastric Adenocarcinoma (MEGAN)WithdrawnNCT02856867Phase 2
- Metronomic Chemotherapy in Advanced Gastric CancerStatus unknownNCT02855788Phase 2
- Impact of a Booklet-Question List on Cancer Patients or Their Families Seeking Prognostic Information During a Palliative Care ConsultationCompletedNCT02854293
- CAR-T Hepatic Artery Infusions or Pancreatic Venous Infusions for CEA-Expressing Liver Metastases or Pancreas CancerCompletedNCT02850536Phase 1
- An Image-guided SBRT for Adrenal Gland Metastasis in Oligometastatic PatientsStatus unknownNCT02848196Not applicable
- Differentiated Resistance Training of the Paravertebral Muscles in Patients With Unstable Spinal Bone Metastasis Under Concomitant RadiotherapyStatus unknownNCT02847754Phase 2
- Allogenic Immunotherapy Based on Natural Killer (NK) Cell Adoptive Transfer in Metastatic Gastrointestinal Carcinoma Treated With CetuximabCompletedNCT02845999Phase 1
- Adjuvant Oral Decitabine and Tetrahydrouridine With or Without Celecoxib in People Undergoing Pulmonary MetastasectomyWithdrawnNCT02839694Phase 1
- Evaluation of Medical Practice in the Management of Bone Metastases After Injectable Bone Antiresorptive Treatment, and Its Influence on Quality of LifeActive, not recruitingNCT02839291Not applicable
- Study of Genetic and Cellular Immunological Parameters Predictive of Disease-free Survival in Patients With Metastatic CancerCompletedNCT02838381Not applicable
- Essential Oils on Anxiety of Patients Suffering From CancerTerminatedNCT02835352Not applicable
- Image-guided and Intensity-modulated Radiotherapy Versus External Beam Radiotherapy for Patients With Spine MetastasesStatus unknownNCT02832830Phase 2
- Intensity-modulated Radiotherapy With Integrated-boost in Patients With Spinal Bone MetastasesStatus unknownNCT02832765Phase 2
- A Clinical Trial on Whole-brain Radiotherapy With Temozolomide Concurrent Chemotherapy or Avoidance of Hippocampus for Patients of Brain MetastasesStatus unknownNCT02832635Phase 2
- Investigation of the Optimal Calcium Supplement Following Roux-en-Y Gastric BypassCompletedNCT02830789Not applicable
- Metastatic Tumor Research and Outcomes NetworkCompletedNCT02830451
- Precarious Elderly Patient Supported For Cancer Impact on Quality Of Life of a Domotic And Remote Assistance Approach for Elderly Patients Supported For Locally Advanced or Metastatic Cancer, Socially IsolatedStatus unknownNCT02829762Not applicable
- Preliminary Evaluation of Uptake in Bone Metastases and Biodistribution of [68Ga]P15-041CompletedNCT02826382Early Phase 1
- Radiosensitization of Multiple Brain Metastases Using AGuIX Gadolinium Based NanoparticlesCompletedNCT02820454Phase 1
- Nivolumab in Combination With Plinabulin in Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC)CompletedNCT02812667Phase 1
- Personalized Cellular Vaccine for Brain Metastases (PERCELLVAC3)CompletedNCT02808416Phase 1
- Utility of Intra-operative Image Guidance System for Missing MetastasesCompletedNCT02806037
- A Multi-center Prospective Observational Biomarker Study on EGFRm+ Non-small Cell Lung Cancer Patients With Leptomeningeal MetastasisStatus unknownNCT02803619
- A Clinical Trial of Stereotactic Ablative Radiotherapy for Metastatic LymphadenopathyStatus unknownNCT02803151Not applicable
- Epidural Anesthesia-analgesia and Long-term Survival After Lung Cancer SurgeryCompletedNCT02801409Not applicable
- Safety and Pharmacokinetics (PK) of Escalating Doses of Tiragolumab as a Single Agent and in Combination With Atezolizumab and/or Other Anti-Cancer Therapies in Locally Advanced or Metastatic TumorsCompletedNCT02794571Phase 1
- Comparing of Modified Wet Suction Technique and Dry Suction Technique for EUS-FNA of Solid Occupying LesionsStatus unknownNCT02789371Not applicable
- Efficacy of Radiotherapy in Combination With Zoledronic Acid in Bone Metastasis Patients With Gastrointestinal TumorsCompletedNCT02784652Phase 2
- Diffusion-Weighted MRI for Liver MetastasisCompletedNCT02781935
- Culture of Circulating Tumor Cells Isolated From Cancer Patients With Metastatic DiseaseCompletedNCT02781025
- Gene-Modified T Cells, Vaccine Therapy, and Nivolumab in Treating Patients With Stage IV or Locally Advanced Solid Tumors Expressing NY-ESO-1CompletedNCT02775292Phase 1
- Kypho-IORT vs. EBRT in Spinal MetastasesTerminatedNCT02773966Phase 3
- Efficacy of PET/MRI in Detecting Metastatic Disease in Endometrial CancerTerminatedNCT02765698
- Associating Liver Partition With Portal Vein Ligation for Staged Hepatectomy (ALPPS) vs. Two-Stage Hepatectomy (TSH) for Marginally Resectable Colorectal Liver Metastases (CRLM)Status unknownNCT02758977Not applicable
- Stereotactic Radiotherapy for Oligo-Progressive Metastatic Cancer (The STOP Trial)Active, not recruitingNCT02756793Not applicable
- Expanded Access to ANG1005 for Individual PatientsNo longer availableNCT02755987
- Whole Brain Radiation Using IMRT for Patients With Brain MetastasesCompletedNCT02753790Not applicable
- Assessment of Bone Biomarkers for TKI Response in RCC With Bone Metastases, HRQoL and Comparison of Imaging TechniquesTerminatedNCT02747173
- Can Epidermal Growth Factor Receptor Improve the Postoperative Survivorship for Inoperable Non-small Cell Lung Cancer With Spinal Metastasis ?CompletedNCT02740894
- Intracranial Activity of AZD9291 (TAGRISSO) in Advanced EGFRm NSCLC Patients With Asymptomatic Brain MetastasesStatus unknownNCT02736513Phase 2
- Combination of SABR and L19-IL2 in Patients With Stage IV Lung Cancer (ImmunoSABR)WithdrawnNCT02735850Phase 2
- 64-Cu Labeled Brain PET/MRI for MM-302 in Advanced HER2+ Cancers With Brain MetsWithdrawnNCT02735798Early Phase 1
- PROMOTE: Identifying Predictive Markers of Response for Genitourinary CancerActive, not recruitingNCT02735252Not applicable
- Clinical Evaluation of the Treatment of Intellectual Metastases by Radiosurgery Gamma Knife by Means of a Support System by Mask.CompletedNCT02732769Not applicable
- Local Radiotherapy Following Complete Resection of a Brain MetastasisTerminatedNCT02729558Not applicable
- Efficacy of HIFU-AR on Blood Loss Reduction in Patients With Liver Metastases Requiring HepatectomyTerminatedNCT02728167Not applicable
- Open vs Laparoscopic Liver Surgery for Colorectal Liver MetastasesCompletedNCT02727179Not applicable
- High Dose Icotinib With Sequential SRS For NSCLC Patients Harboring EGFR Mutation With Brain MetastasesStatus unknownNCT02726568Phase 2
- Randomized Embolization Trial for NeuroEndocrine Tumor Metastases to the LiverCompletedNCT02724540Phase 2
- 4-weekly Versus 12-weekly Administration of Bone-targeted Agents in Patients With Bone MetastasesCompletedNCT02721433Phase 4